Merrimack Pharmaceuticals, Inc.

NASDAQ:MACK

15.13 (USD) • At close May 17, 2024
Bedrijfsnaam Merrimack Pharmaceuticals, Inc.
Symbool MACK
Munteenheid USD
Prijs 15.145
Beurswaarde 223,970,318
Dividendpercentage 0%
52-weken bereik 11.53 - 15.89
Industrie Biotechnology
Sector Healthcare
CEO Mr. Gary L. Crocker M.B.A., MBA
Website https://www.merrimack.com

An error occurred while fetching data.

Over Merrimack Pharmaceuticals, Inc.

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Vergelijkbare Aandelen

Sientra, Inc. logo

Sientra, Inc.

SIEN

0.174 USD

Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc.

CRDL

1.25 USD

Genprex, Inc. logo

Genprex, Inc.

GNPX

0.738 USD

IceCure Medical Ltd logo

IceCure Medical Ltd

ICCM

1.24 USD

Harpoon Therapeutics, Inc. logo

Harpoon Therapeutics, Inc.

HARP

23.01 USD

TScan Therapeutics, Inc. logo

TScan Therapeutics, Inc.

TCRX

2.63 USD

Anebulo Pharmaceuticals, Inc. logo

Anebulo Pharmaceuticals, Inc.

ANEB

1.596 USD

HCW Biologics Inc. logo

HCW Biologics Inc.

HCWB

0.342 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)